President and CEO
Axine Water Technologies
New York, NY, United States
Mark Ralph, President and CEO of Axine Water Technologies, has over 20 years of experience in the pharmaceutical industry. Prior to joining Axine, Mark held diverse roles of increasing responsibility in drug discovery, operations, CRO management, finance, business development, licensing and venture capital investing. He served on the board of directors of three companies in the digital health space (Wellth, xCures and Optina Diagnostics) and represented Boehringer Ingelheim in a fund-in-fund investment.
Mark holds a MS degree in chemistry from Memorial University (Canada) and an MBA with concentration in finance from the University of Connecticut.
Disclosure information not submitted.
Optimized Electrochemical Oxidation for Complete PFAS Destruction
Wednesday, July 10, 2024
11:40am – 11:50am PDT